Comedical competitors

Zippia score 3.6

Comedical main competitors are Takeda Pharmaceuticals U.S.A., Inc., Sanofi Biosurgery Inc, and Axcan Pharma US Inc.

Competitor Summary. See how Comedical compares to its main competitors:

Employees at Takeda Pharmaceuticals U.S.A., Inc. earn more than most of the competitors, with an average yearly salary of $85,837.

Work at Comedical?

Share your experience

Comedical vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Comedical	1980	3.6	Seattle, WA	5	$1.6M	30
Masters Pharmaceutical Inc	-	3.6	-	1	-	-
Sanofi Biosurgery Inc	2000	4.0	Cambridge, MA	1	-	5,600
Axcan Pharma US Inc	1991	4.2	Birmingham, AL	1	$470.4M	525
Adams Respiratory Therapeutics	1997	4.1	Chester, NJ	1	$440.0M	750
TP Orthodontics	1942	3.9	La Porte, IN	1	$26.0M	156
UCB	1928	4.3	Smyrna, GA	3	$5.7B	7,600
Hill Dermaceuticals	-	3.9	Sanford, FL	1	$7.5M	46
Vatech America	1992	3.6	Fort Lee, NJ	1	$5.2M	175
Matrix Distributors	-	3.7	East Brunswick, NJ	1	-	-
Brad Pharm	1985	4.3	Fairfield, NJ	1	$145.0M	300
Primus Pharmaceuticals	2000	3.9	Scottsdale, AZ	1	$17.5M	50
Merrell Pharmaceuticals Inc	-	3.7	Cincinnati, OH	1	-	600
Takeda Pharmaceuticals U.S.A., Inc.	1998	4.7	Deerfield, IL	14	$12.1B	30,481

Rate how well Comedical differentiates itself from its competitors.

Comedical salaries vs competitors

Among Comedical competitors, employees at Takeda Pharmaceuticals U.S.A., Inc. earn the most with an average yearly salary of $85,837.

Compare Comedical salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Comedical	$65,529	$31.50	-
Masters Pharmaceutical Inc	$58,285	$28.02	-
Sanofi Biosurgery Inc	$76,825	$36.94	-
Axcan Pharma US Inc	$71,660	$34.45	-
Adams Respiratory Therapeutics	$71,350	$34.30	-
TP Orthodontics	$55,153	$26.52	-

Compare Comedical job title salaries vs competitors

Company	Highest salary	Hourly salary
Comedical	$70,932	$34.10
Takeda Pharmaceuticals U.S.A., Inc.	$77,428	$37.23
Axcan Pharma US Inc	$76,793	$36.92
Adams Respiratory Therapeutics	$75,081	$36.10
Hill Dermaceuticals	$72,920	$35.06
UCB	$72,636	$34.92
Primus Pharmaceuticals	$72,356	$34.79
Merrell Pharmaceuticals Inc	$72,260	$34.74
Brad Pharm	$72,231	$34.73
Sanofi Biosurgery Inc	$72,004	$34.62
Masters Pharmaceutical Inc	$71,741	$34.49
Vatech America	$71,598	$34.42
TP Orthodontics	$71,143	$34.20
Matrix Distributors	$71,017	$34.14

Do you work at Comedical?

Does Comedical effectively differentiate itself from competitors?

Comedical jobs

Comedical demographics vs competitors

Compare gender at Comedical vs competitors

Job title	Male	Female
Primus Pharmaceuticals	46%	54%
UCB	47%	53%
Takeda Pharmaceuticals U.S.A., Inc.	49%	51%
Comedical	-	-

Male

Female

100%

75%

50%

25%

Comedical

Takeda Pharmaceuticals U.S.A., Inc.

UCB

Primus Pharmaceuticals

25%

50%

75%

100%

Compare race at Comedical vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Takeda Pharmaceuticals U.S.A., Inc.	61%	13%	11%	12%	4%	9.7
UCB	59%	13%	15%	10%	4%	9.8
Primus Pharmaceuticals	60%	21%	11%	5%	4%	6.6

Comedical and similar companies CEOs

CEOBio

John Fraher

Axcan Pharma US Inc

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Daniel Glassman

Brad Pharm

Jean-Christophe Tellier

UCB

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents

James D. Weir

Primus Pharmaceuticals

J.D. Weir is a Chief Executive Officer at PRIMUS PHARMACEUTICALS INC and is based in United States.

Andrew Kesling

TP Orthodontics